SurModics develops surface modification and drug delivery technologies to enhance medical device performance in healthcare.

SurModics (NASDAQ:SRDX) specializes in the development and commercialization of surface modification and drug delivery technologies. These advancements empower medical devices and in vitro diagnostics to perform more effectively, which in turn, supports healthcare professionals in providing better care. With a keen focus on innovation, SurModics endeavors to tackle unmet medical needs by enhancing the performance and reliability of medical devices. Their projects range from coating technologies that improve the functionality and compatibility of medical devices to drug-coated balloons for the treatment of peripheral arterial disease. With objectives firmly set on advancing healthcare solutions, SurModics is committed to pushing the boundaries of medical technology to improve patient outcomes and create value for its stakeholders.